This list of causes of basal cell carcinoma is by no means comprehensive. If you think you might have a basal cell carcinoma or a squamous cell carcinoma, speak with your doctor right away. Repeated or Over-Exposure to Ultraviolet Light Exposure to the sun’s rays (or from tanning beds) is considered to be the largest […]
Blog
Sensus Healthcare issues letter to stockholders
BOCA RATON, Fla., April 24, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that Joe Sardano, chairman and chief executive officer issued today the following letter to stockholders: Dear Fellow Stockholder: Our first annual stockholders’ […]
Alternative to Mohs Surgery: SRT-100™
Since the 1930s, doctors have successfully treated various forms of skin cancer, including basal cell carcinoma and squamous cell carcinoma, the most common forms of skin cancer, using Mohs micrographic surgery. Today, Mohs surgery is the most widely accepted and utilized treatment for skin cancer with cure rates of over 98%. However, there are many […]
Superficial Radiotherapy: The Non-Invasive Skin Cancer Treatment Option for You
If you have been diagnosed with non-melanoma skin cancer such as basal cell or squamous cell carcinoma, there are multiple options for treatment. Invasive Options With Mohs surgery, surgeons slice thin layers of skin from your body, test the cells for cancer, and continue until the tests come back negative. Mohs surgery offers high success […]
Resurgence of cutaneous radiation therapy for skin cancer: Healio Interview with Dr. Clay Cockerell
This video is part of Healio’s video perspective series from the 2017 AAD Annual Meeting conference and has been published with the headline, “Resurgence of cutaneous radiation therapy for skin cancer.” During the two-minute video, Dr. Cockerell discusses the resurgence of radiation therapy largely due to new technology developed by Sensus Healthcare which ultimately provides […]
Superficial Radio Therapy: The Non-Invasive Skin Cancer Treatment Option for Your Patients
If you have patients diagnosed with non-melanoma skin cancer such as basal cell or squamous cell carcinoma, you know there are multiple options available for treatment. Invasive Options With Mohs surgery, surgeons slice thin layers of skin from the body, test those cells for cancer, and continue surgery until the tests come back negative. Mohs […]
SRT-100 Physician Dr. Jeremy Sunseri Flashes Back to Rodeo Days
Below is a photo of Sensus Healthcare customer Jeremy Sunseri, MD, FAAD, of Sun Dermatology in Panama City, FL during his rodeo days.
Sensus Healthcare Chief Financial Officer Arthur Levine Photographed with Basketball Icon and Hall of Famer, Bill Walton
Sensus Healthcare Chief Financial Officer Arthur Levine attended the ROTH Capital Conference at Dana Point, CA. and is seen below with Basketball Icon and Hall of Famer, Bill Walton.
Dr. David J Goldberg Presents at AAD 2017
Superficial radiation advances as option for NMSC treatment David J. Goldberg, MD, JD, examined the genesis of the evolution of superficial radiation therapy (SRT) during “New and Emerging Therapies for Non-Melanoma Skin Cancers,” part of “New Emerging Therapies” (S022). Dr. Goldberg is a dermatologic surgeon at Skin Laser and Surgery Specialists of New York/New Jersey. […]
Sensus Healthcare to Present at the 29th Annual ROTH Conference
BOCA RATON, Fla., March 7, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced that Joe Sardano, the Company’s chief executive officer, will present a corporate overview at the 29th Annual ROTH Conference on Wednesday, […]
SRT Therapy vs Mohs Surgery
For a long time, patients suffering from non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma only had one option to turn to for successful treatment. Mohs surgery, developed by general surgeon Frederik E. Mohs in 1938, involves removing one thin layer of tissue from the afflicted area at a time and […]
SRT-100 Vision featured on San Antonio News
SRT-100 Vision a New Technology Revolutionizing Skin Cancer Treatment Skin cancer—it’s the most common cancer in the United States. An estimated one in five Americans will develop skin cancer in their lifetimes, but there’s a new technology that’s revolutionizing how patients are treated and it’s in the San Antonio area. “I’ve had skin cancers now […]
Superficial radiation therapy offers an effective alternative to Mohs surgery
Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or improving patients’ quality of life. Below is an excerpt from the article by Healio.com covering this presentation: MIAMI — Superficial […]
Superficial radiation therapy provides safe, aesthetic results for non-melanoma skin cancer patients
MIAMI — At South Beach Symposium 2017, symposium chairman Mark S. Nestor, MD, PhD, discusses the efficacy and cosmetic benefits of superficial radiation therapy to treat both non-melanoma skin cancer and recurring keloid scars. Nestor presented at the symposium on innovative breakthroughs in superficial radiation therapy, including new technology from Sensus Healthcare. To watch the […]
Sensus Healthcare to Participate in 2017 South Beach Symposium on February 9 – 12 in Miami
— Joe Sardano, Sensus Healthcare CEO, to Participate in CEO Forum on February 11 — Sensus Healthcare Medical Advisory Board Members to Host SRT Workshops on February 9 BOCA RATON, Fla., Feb. 7, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2016 Results
– Record Quarterly Revenues of $4.9 million in Fourth Quarter – Full Year 2016 revenues increased 44% year-over-year to $14.8 million – Worldwide installed base increased to 271 units BOCA RATON, Fla., Feb. 2, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other […]
Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
BOCA RATON, Fla., Jan. 19, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that it will report its fourth quarter and full year 2016 financial results on Thursday, February 2, 2017 […]
SRT-100™: The Doctor’s Choice for Treatment of Non-Melanoma Basal Cell Cancer
Giving a skin cancer diagnosis to a patient is never easy. The word “cancer” is a scary word for any patient to hear. Sadly, one in five Americans will develop skin cancer over the course of their lifetime and 40 to 50 percent of Americans who live to age 65 will have either basal cell […]
Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th – 11th in San Francisco
BOCA RATON, Fla., Jan. 3, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), today announced that Joe Sardano, CEO and Arthur Levine, CFO will participate in the Annual JP Morgan Healthcare […]
Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment
Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently had the chance to chat with the company’s CEO Joseph C. Sardano, who shared some insight into the company and […]